DMDoaa Atef Moubarez

Doaa Atef Moubarez

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Doaa Atef Moubarez has a total of 15 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Role of the C-reactive protein/albumin ratio as a predictor of new-onset atrial fibrillation in critically ill patients

    by Doaa Atef Moubarez

    Background: New-onset atrial fibrillation (NOAF) is a prevalent arrhythmia in critically ill cases. Serious mortality and morbidity are associated with it. The objective of this study was to assess the predictive value of the C-reactive protein (CRP)/albumin ratio (CAR) in critically ill patients admitted to the intensive care unit (ICU) regarding the occurrence of NOAF. Results: The participants in this observational research comprised 360 critically ill cases who were divided into two categories according to the onset of AF. Albumin and CRP levels in the serum were determined. CRP level divided by albumin level yielded the CAR ratio. NOAF predictors were identified utilizing multiple logistic regression analysis (MLRA). NOAF was found in 18 (5%) of the patients. The CAR was greater in cases with NOAF than in cases without NOAF (p < 0.001). The CAR was an independent predictor of NOAF according to MLRA (95% confidence interval (CI): 1.219-1.836; odds ratio (OR) = 1.496; p < 0.001). CAR exhibited a significantly larger area under the receiver operating characteristic (ROC) curves (AUC) in AF prediction compared to CRP (0.878 vs. 0.869; p < 0.001). The CAR cut-off point for AF prediction was 3.1. Additionally, a statistically significant predictor of ICU mortality was identified in CAR (95% CI: 0.848-0.929; AUC: 0.889; p < 0.001). Conclusion: Patients who are critically ill with a high CAR at the time of admission have an increased risk of developing NOAF and worse clinical outcomes during hospitalization.

  • Open Access

    Clinical implications of admission and follow-up urea-to-creatinine ratio in patients with acute decompensated heart failure

    by Doaa Atef Moubarez, Hany Tawfik Fathelbab, El-Sayed Abd- Elhalim Mohammed, Ahmed Samir Elsawy

    Purpose: Acute decompensated heart failure (ADHF) patients with a poor renal function have a worse prognosis. The urea-to-creatinine ratio (UCR) may be a valuable tool for assessing kidney function and stratifying patients with ADHF. We evaluated the value of an admission and follow-up UCR in predicting AKI, 28-day mortality, and rehospitalization in patients with ADHF. Methods: This prospective research comprised sixty patients with ADHF. Based on the mean admission UCR, patients are classified into two groups: the high UCR group (UCR ≥ 42.33) and the low UCR group (UCR < 42.33). On the third day, they are categorized into high UCR and low UCR groups according to the same mean of UCR (42.33). A 28-day follow-up was implemented. Results: Thirty patients (50%) developed AKI, and nine (15%) died during follow-up. In the high UCR group, the development of AKI was considerably more significant than in the low UCR group on the 3rd day (69.2% vs. 35.2%, respectively, p = 0.010). Furthermore, the high UCR group experienced a higher death rate than the low UCR group on the 3rd day (26.9% vs. 5.8%, respectively, p = 0.024). A considerable statistical correlation was reported between UCR and eGFR on the 3rd day (p = 0.025). According to ROC, UCR on the 3rd day was a significant predictor of AKI and 28-day mortality in these patients ((AUC = 0.736 and 0.718, respectively). In contrast, UCR on admission was not a predictor of AKI or 28-day mortality (p = 0.578 and 0.305, respectively). Also, neither admission nor 3rd day UCR could predict HF readmission (p = 0.108 and 0.298, respectively). By the Kaplan–Meier curve, survival rates were highest when UCR ≤ 34.85 and reduced when UCR > 34.85 (p < 0.001). Conclusion: The follow-up UCR is a good predictor of AKI development and elevated 28-day mortality in ADHF patients. Considering its simplicity, this biomarker should be used more systematically in clinical practice.

  • Open Access

    The modified NUTRIC score as a predictor of 28-day mortality in patients with sepsis

    by Doaa Atef Moubarez

    Background: Malnutrition is prevalent among severely ill individuals hospitalized in ICUs (intensive care units). In order to determine the potential for nutritional consequences in ICU patients, the score of ‘modified nutrition risk in the critically ill’ (mNUTRIC) is applied. This research aimed to determine whether the mNUTRIC score could be employed in septic patients for predicting 28-day death. Methods: Four hundred ten individuals hospitalized in the ICU with sepsis were involved in this prospective observational research. To evaluate nutritional status upon hospitalization to the ICU, the mNUTRIC score was applied. Demographic and clinical characteristics were used to determine the mNUTRIC score. Results: Four hundred ten individuals with sepsis participated in this investigation. The 56.6% of cases were shown to be at elevated risk of malnutrition (mNUTRIC ≥ 5 points), whereas 43.4% showed a lower risk (mNUTRIC < 5 points). During 28 days of being hospitalized in the ICU, 225 patients (54.9%) died. The mortality rate increased significantly in the group with an mNUTRIC score of greater than or equal to 5 compared with the group with an mNUTRIC score of less than 5 (P < 0.001). Multivariate analysis revealed a link between the mNUTRIC score and 28-day mortality (OR = 1.715, 95% CI = 1.549–1.898). The AUC (area under the curve) for mNUTRIC’s prediction of 28-day mortality was 0.866 (specificity 79.5% and sensitivity 80.9%) with the best cut-off value of 5. Conclusion: When evaluating the likelihood of death within 28 days in patients with sepsis, the mNUTRIC score performed well as an independent predictor.


  • Open Access

    Identifying Independent Predictors of Mortality in COVID-19 Patients with Mucormycosis

    by Mohamed G Hamed, Abdelmonem Awad Hegazy, Ahmed Embaby, Shimaa Abdelmoneem, Amany Abd Al Badea, Ali Awad, Mohammad Walaa, Mai Ahmed Gobran, Omnia Awwad, Doaa AbdElmonem, et al.

    Background: Coronavirus disease 2019 (COVID-19) may lead to immunosuppression, leaving patients vulnerable to secondary invasive fungal infection like mucormycosis. The present study aimed to determine whether there are any risk factors associated with mortality in mucormycosis among COVID-19 patients. Patients and Methods: Patients with COVID-19 diagnosed with mucormycosis who received treatment at University Hospitals were included in the study. Complete blood count (CBC), glycated hemoglobin (HBA1c), C-reactive protein (CRP), serum albumin level, creatinine, ferritin levels, lactate dehydrogenase (LDH), D-dimer and histopathological observations were performed for all participants’ specimens. Results: The number (N) of patients included in the study was 46. About 85 % (39/46) of patients had post-COVID-19 syndrome and the other 7 cases were in the active phase of the disease. CRP, serum ferritin, D-dimer, CRP/albumin ratio and CRP/absolute lymphocyte counts were statistically significant (P<0.05) within non-survivors as compared to survivors. After analysis of multivariate analysis that patients had oxygen support, while elevated CRP/albumin ratios were independent predictors of mortality in COVID-19 patients associated with mucormycosis. Conclusions: Mucormycosis can be caused by immunosuppression conditions associated with COVID-19 infection. Oxygen levels and C-reactive protein/albumin are independent predictors of mortality and morbidity in post COVID-19 patients.

  • Open Access

    The predictive value of serum uric acid in development of acute kidney injury and mortality in patients with sepsis

    by Doaa Atef Moubarez

    Introduction: Acute kidney injury (AKI) and sepsis are significant causes of morbidity and mortality in intensive care units. Therefore, early screening of high-risk individuals is critical for preventing AKI and improving outcomes. Objectives: To examine the possible involvement of uric acid in predicting AKI and mortality in septic patients. Patients and Methods: A prospective study recruited 400 patients with sepsis based on the quick Sequential Organ Failure Assessment (qSOFA) criteria who were hospitalized in the intensive care unit (ICU). Patients were categorized into two groups depending on their uric acid levels; those with a serum uric acid ≥7 mg/dL and those with a serum uric acid Results: A total of 400 septic patients were included in this study. Among them, 52.5% (210/400) patients had hyperuricemia during admission to the ICU. A total of 177/400 (44.2%) patients developed AKI. The likelihood of having hyperuricemia in association with AKI was 65.6%. Meanwhile, the likelihood of having a uric acid level of less than 7 mg/dL in association with AKI was 23.9% (PPP= 0.002). Receiver operating characteristic (ROC) curves revealed that uric acid has a high predictive value for AKI and ICU mortality in patients with sepsis. Conclusion: Serum uric acid could be a marker to predict AKI and mortality in patients with sepsis.